Back
Pulmonx Corp. 10K Form
Sell
17
LUNG
Pulmonx Corp.
Last Price:
$1.33
Seasonality Move:
-24.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-15 | 10K | LUNG/Pulmonx Corp. Annual |
| 2020-11-13 | 10Q | LUNG/Pulmonx Corp. Quarterly |
Receive LUNG News And Ratings
See the #1 stock for the next 7 days that we like better than LUNG
LUNG Financial Statistics
Sales & Book Value
| Annual Sales: | $90.5M |
|---|---|
| Cash Flow: | $-7.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.30 |
| Price / Book: | 1.08 |
Profitability
| EPS (TTM): | -1.32960 |
|---|---|
| Net Income (TTM): | $-54M |
| Gross Margin: | $67M |
| Return on Equity: | -77.88% |
| Return on Assets: | -36.59% |
Pulmonx Corp. Earnings Forecast
Key Pulmonx Corp. Financial Ratios
-
The Gross Profit Margin over the past 8 years for LUNG is 74.08%.
-
The Selling, General & Administrative Expenses for LUNG have been equal to 111.95% of Gross Profit Margin.
-
The Research & Development expenses have been 21.54% of Revenue.
-
The Net Earning history of LUNG is -59.67% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Pulmonx Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | LUNG |
| CUSIP: | 745848 |
| Website: | pulmonx.com |
Debt
| Debt-to-Equity Ratio: | 1.04 |
|---|---|
| Current Ratio: | 5.06 |
| Quick Ratio: | 4.1 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LUNG Technical Analysis vs Fundamental Analysis
Sell
17
Pulmonx Corp. (LUNG)
is a Sell
Is Pulmonx Corp. a Buy or a Sell?
-
Pulmonx Corp. stock is rated a SellThe current Pulmonx Corp. [LUNG] share price is $1.33. The Score for LUNG is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.